Company profile
UK company 08795000, incorporated on 28 November 2013.
Accelerating Biomedical Innovation | Drug Development | ValiRx
ValiRx provides the scientific, financial and commercial framework to accelerate biomedical innovations for effective and efficient drug development
Company number 08795000
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
AD01 | Transaction MzUyNzI5NTE2M2FkaXF6a2N4
Published 19 Jun 2026 11:58
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jan 2014 to 31 Dec 2015
Some cancerous tumors require, or grow faster in the presence of, steroid hormones such as estrogen or testosterone. These cancers can be treated by chemotherapy drugs to prevent the tumor using hormones found naturally in the body. Many of these drugs work by blocking the receptors for the hormone on the outside edges of the tumor, starving the tumor by ...
